Pigmentary disorders, prevalence, impact on quality of life, social stigmatization: results of the first large international survey

T. Passeron, L. Wei, A. Morita, C.L Goh, A. Alexis, B. Dreno, H.Y. Kang, F. Ly, S. Puig, S. Schalka, J. Ocampo Candiani, A.L Demessant C. Le Floc’h ,D. Kerob, J. Krutmann, H.W. Lim

    La Roche-Posay
  • Publication date: July 2024
  • Updated date: September 2026
  • Reading time: 10 min

1WCD2023_IMG


INTRODUCTION & OBJECTIVES


Pigmentary disorders (PD) such as Melasma, Post-inflammatory Hyperpigmentation (PIH), Solar Lentigo, Vitiligo, Peri-Orbital Hyperpigmentation (POH) and Axillary Hyperpigmentation (AH) are frequent dermatological conditions, but little is known on their real-world prevalence and impact. This first worldwide survey evaluates the prevalence of PD and its impact on quality of life (QOL) and stigmatization.